First National Corp Eli Lilly & CO Transaction History

First National Corp

$449 Million
Q3 2024

A detailed history of First National Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, First National Corp holds 4,350 shares of LLY stock, worth $3.25 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares

4,350

Previous 6,059 28.21%

Holding current value

$3.25 Million

Previous $5.49 Million 29.75%

% of portfolio

0.86%

Previous 1.31%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$772.14 - $960.02 $1.32 Million - $1.64 Million	-1,709 Reduced 28.21%	4,350 $3.85 Million
Q2 2024 Jul 12, 2024	SELL	$724.87 - $909.04 $662,531 - $830,862	-914 Reduced 13.11%	6,059 $5.49 Million
Q4 2023 Jan 18, 2024	SELL	$525.19 - $619.13 $186,442 - $219,791	-355 Reduced 4.84%	6,973 $4.06 Million
Q3 2023 Oct 24, 2023	SELL	$434.7 - $599.3 $28,690 - $39,553	-66 Reduced 0.89%	7,328 $3.94 Million
Q2 2023 Jul 31, 2023	SELL	$350.74 - $468.98 $188,347 - $251,842	-537 Reduced 6.77%	7,394 $3.47 Million
Q1 2023 Apr 27, 2023	SELL	$310.63 - $364.82 $8,697 - $10,214	-28 Reduced 0.35%	7,931 $2.72 Million
Q4 2022 Jan 26, 2023	SELL	$321.55 - $374.67 $9,003 - $10,490	-28 Reduced 0.35%	7,959 $0
Q3 2022 Oct 24, 2022	SELL	$296.48 - $337.87 $97,541 - $111,159	-329 Reduced 3.96%	7,987 $2.58 Million
Q2 2022 Jul 18, 2022	SELL	$278.73 - $327.27 $22,855 - $26,836	-82 Reduced 0.98%	8,316 $2.7 Million
Q1 2022 Apr 26, 2022	SELL	$234.69 - $291.66 $78,386 - $97,414	-334 Reduced 3.83%	8,398 $2.41 Million
Q4 2021 Jan 28, 2022	SELL	$224.85 - $279.04 $96,010 - $119,150	-427 Reduced 4.66%	8,732 $2.41 Million
Q3 2021 Nov 09, 2021	SELL	$221.6 - $272.71 $140,494 - $172,898	-634 Reduced 6.47%	9,159 $2.12 Million
Q2 2021 Jul 30, 2021	BUY	$180.55 - $233.54 $70,053 - $90,613	388 Added 4.13%	9,793 $1.61 Million
Q1 2021 May 10, 2021	SELL	$164.32 - $212.72 $4,272 - $5,530	-26 Reduced 0.28%	9,405 $1.76 Million
Q4 2020 Feb 08, 2021	SELL	$130.46 - $172.63 $44,878 - $59,384	-344 Reduced 3.52%	9,431 $1.59 Million
Q3 2020 Oct 22, 2020	SELL	$146.22 - $169.13 $2,631 - $3,044	-18 Reduced 0.18%	9,775 $2.21 Million
Q2 2020 Jul 21, 2020	SELL	$136.42 - $164.18 $9,276 - $11,164	-68 Reduced 0.69%	9,793 $1.61 Million
Q1 2020 Apr 16, 2020	SELL	$119.05 - $147.35 $26,667 - $33,006	-224 Reduced 2.22%	9,861 $7.83 Million
Q4 2019 Jan 31, 2020	SELL	$106.92 - $132.43 $15,182 - $18,805	-142 Reduced 1.39%	10,085 $1.33 Million
Q2 2019 Jul 30, 2019	SELL	$110.79 - $129.32 $42,321 - $49,400	-382 Reduced 3.6%	10,227 $1.13 Million
Q1 2019 Jun 12, 2019	SELL	$111.31 - $131.02 $81,924 - $96,430	-736 Reduced 6.49%	10,609 $164,000
Q4 2018 Jun 12, 2019	BUY	$105.9 - $118.64 $1.2 Million - $1.35 Million	11,345 New	11,345 $1.31 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Corp , based on Form 13F filings with the SEC.

News

Stay updated on First National Corp with notifications on news.

Account

First National Corp Eli Lilly & CO Transaction History